| |
|
|
|
Vistagen Therap. Com  
|
|
2.92 0 (0%) |
09-16 16:00 |
|
Open: |
2.93 |
Pre close: |
2.92 |
Target:
|
3.81
|
|
High: |
3 |
Low: |
2.87 |
Resistance:
|
3.26
3.81
|
|
Volume: |
587,264 |
Market Cap: |
563M |
Support:
|
2.83
2.56
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.96
 |
MACD |
MACD(12,26):
|
0.04 |
|
MA(20): |
2.98  |
Signal(12,26,9): |
0.06 |
|
MA(100): |
2.77 |
Stochastic Oscillator |
%K(14,3):
|
22.65 |
|
MA(250): |
2.03 |
%D(3): |
34.96 |
|
Average Volume(K) |
3-Month: |
3825296
|
52-Week |
High:
|
3.55 |
|
10-Days: |
2067658 |
Low: |
0.56 |
|
RSI |
RSI(14):
|
48.28 |
Change(%): |
356.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.265 |
Return on Equity (ttm) |
-49.0 |
Shares Out. (M) |
190.20 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-25.6 |
Shares Float (M) |
139.44 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.28 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
69.31 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
0.006 |
Shares Short (K) |
10890 |
|
Book Value (p.s.) |
0.680 |
EBITDA (p.s.) |
-0.118 |
P/E |
-11.02 |
|
Sales Per Share |
0.008 |
Qtrly Earnings Growth |
0.00 |
P/BV |
4.29 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-15.44 |
P/S |
385.68 |
|
Operating Margin |
-1562.64 |
Levered Free Cash Flow
(M) |
-9.39 |
P/CF |
-35.97 |
|
|
|
|
|
|
